Your browser doesn't support javascript.
loading
Response prediction biomarkers and drug combinations of PARP inhibitors in prostate cancer.
Chen, Yi-Xin; Tan, Li-Ming; Gong, Jian-Ping; Huang, Ma-Sha; Yin, Ji-Ye; Zhang, Wei; Zhou, Hong-Hao; Liu, Zhao-Qian.
Affiliation
  • Chen YX; Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, and National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Tan LM; Institute of Clinical Pharmacology, Engineering Research Center for Applied Technology of Pharmacogenomics of Ministry of Education, Central South University, Changsha, 410078, China.
  • Gong JP; Department of Pharmacy, The Second People's Hospital of Huaihua City, Huaihua, 418000, China.
  • Huang MS; Department of Pharmacy, The Second People's Hospital of Huaihua City, Huaihua, 418000, China.
  • Yin JY; Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, and National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Zhang W; Institute of Clinical Pharmacology, Engineering Research Center for Applied Technology of Pharmacogenomics of Ministry of Education, Central South University, Changsha, 410078, China.
  • Zhou HH; Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, and National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Liu ZQ; Institute of Clinical Pharmacology, Engineering Research Center for Applied Technology of Pharmacogenomics of Ministry of Education, Central South University, Changsha, 410078, China.
Acta Pharmacol Sin ; 42(12): 1970-1980, 2021 Dec.
Article in En | MEDLINE | ID: mdl-33589795
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Biomarkers / Poly(ADP-ribose) Polymerase Inhibitors / Antineoplastic Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Acta Pharmacol Sin Journal subject: FARMACOLOGIA Year: 2021 Document type: Article Affiliation country: China Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Biomarkers / Poly(ADP-ribose) Polymerase Inhibitors / Antineoplastic Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Acta Pharmacol Sin Journal subject: FARMACOLOGIA Year: 2021 Document type: Article Affiliation country: China Country of publication: United States